drugset / Trial / NCT00099879

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

NCT00099879 ↗

Phase 2 Terminated Bristol-Myers Squibb
RandomizedTreatment

Summary

The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.

Timeline

Start
—
Primary completion
2006-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-275183 Small molecule — —